trending Market Intelligence /marketintelligence/en/news-insights/trending/cukcamtafbclwoba8g4_sw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Akcea Therapeutics names Ionis exec to its board

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Akcea Therapeutics names Ionis exec to its board

Akcea Therapeutics Inc. named Damien McDevitt to its board.

McDevitt is the chief business officer of Akcea's parent, Ionis Pharmaceuticals Inc. He will replace Stanley Crooke Ionis' founder, chairman and CEO — who has resigned from Akcea's board.

Before joining Ionis in June, McDevitt was senior vice president of corporate development at Acadia Pharmaceuticals Inc. He had also served in various global and strategic business roles at GlaxoSmithKline PLC.

Cambridge, Mass.-based Akcea Therapeutics is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and rare diseases.